AGOBLISS 25 TAB by Dr Precision is a premium pharmaceutical formulation containing 25 mg of Agomelatine, a novel antidepressant designed specifically for the treatment of major depressive disorder (MDD) in adults. This medication uniquely targets melatonergic MT1 and MT2 receptors as an agonist while antagonizing 5-HT2C serotonin receptors, enabling the resynchronization of disturbed circadian rhythms commonly associated with depressive episodes. AGOBLISS 25 improves mood, sleep quality, and emotional stability without causing daytime sedation or sexual dysfunction often seen with traditional antidepressants. Its rapid onset of action and sustained efficacy make it ideal for patients with sleep disturbances, fatigue, and motivational deficits related to depression. Manufactured under Dr Precision's GMP-compliant protocols, AGOBLISS 25 offers high-quality, stable, and consistent dosing in convenient once-daily tablets. As a well-tolerated therapy supported by clinical evidence, it provides an effective alternative to SSRIs and SNRIs with fewer side effects, making it a valuable addition to mental health treatment portfolios and pharmaceutical manufacturing partnerships seeking quality antidepressant formulations for global markets.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Agomelatine 25 mg per tablet |
| Mechanism of Action | Melatonergic MT1/MT2 agonist and 5-HT2C antagonist |
| Indication | Major Depressive Disorder (MDD) in adults |
| Dosing | Once daily, preferably at bedtime |
| Therapeutic Benefits | Improves mood, sleep quality, emotional stability without sedation |
| Tolerability Profile | Low incidence of sexual dysfunction, weight gain, and discontinuation symptoms |
| Onset of Action | Clinical effects begin within two weeks |
| Manufacturing Standards | WHO-GMP and ISO certified |
| Packaging | Blister packs for product integrity and easy distribution |
| Support Services | Regulatory assistance, product dossiers, export documentation available |
| Attributes | Description |
|---|---|
| Dosage Form | Tablet |
| Dosage Strength | 25 mg Agomelatine |
| Pharmacological Class | Antidepressant (melatonergic agonist and serotonin antagonist) |
| Manufacturing Compliance | GMP, WHO-GMP and ISO certified facilities |
| Shelf Life | As per regulatory standards (typically 2 years) |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Packaging Type | Blister pack |
| Prescription Status | Prescription only medicine |
| Safety Precaution | Requires liver function monitoring during treatment |
| Manufacturer | Dr Precision (under BluepillExpress partnership) |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
AGOBLISS 25 TAB uniquely combines melatonergic MT1 and MT2 receptor agonism with 5-HT2C serotonin receptor antagonism, restoring circadian rhythms and improving sleep quality alongside mood regulation. Unlike typical SSRIs/SNRIs, it shows fewer side effects such as sexual dysfunction, weight gain, and discontinuation syndrome.
Yes, due to the possibility of hepatotoxicity in susceptible individuals, regular liver enzyme tests are recommended, particularly during the first months of treatment, to ensure patient safety.
Clinical improvements in mood, sleep, and emotional stability typically begin within two weeks of starting AGOBLISS 25 therapy and improve further with continued use.
Yes, AGOBLISS 25’s mechanism supports resynchronization of circadian rhythms and enhances sleep quality, making it particularly useful for patients whose depression includes sleep disturbances or circadian rhythm disruptions.
AGOBLISS 25 TAB is produced under strict WHO-GMP and ISO certified processes by Dr Precision, ensuring pharmaceutical-grade quality, consistent potency, and product stability.
Yes, Dr Precision offers flexible contract manufacturing and private labeling options for AGOBLISS 25 TAB, supported by comprehensive regulatory and export documentation services.
Country Of Origin: India
AGOBLISS 25 TAB contains Agomelatine 25 mg, a novel antidepressant used in the treatment of major depressive disorder (MDD) in adults. It acts as a melatonergic agonist and a serotonin antagonist, restoring circadian rhythms and improving mood, sleep, and emotional stability. AGOBLISS 25 is known for its unique mechanism and favorable tolerability profile.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
AGOBLISS 25 TAB is a pharmaceutical formulation containing Agomelatine 25 mg, a next-generation antidepressant known for its innovative approach to treating major depressive disorder (MDD). Unlike conventional antidepressants that primarily target monoamine neurotransmitters, Agomelatine acts as an agonist at melatonergic MT1 and MT2 receptors and as an antagonist at the 5-HT2C serotonin receptors. This dual mechanism helps in the resynchronization of circadian rhythms, which are often disrupted in patients suffering from depression. By regulating the sleep-wake cycle and promoting the release of dopamine and noradrenaline in the frontal cortex, AGOBLISS 25 effectively improves mood and restores emotional stability.
AGOBLISS 25 TAB is particularly valuable for individuals whose depression is accompanied by sleep disturbances, fatigue, and loss of motivation. It enhances sleep quality without causing daytime sedation or impairing alertness. Clinical studies have demonstrated that Agomelatine not only reduces depressive symptoms but also lowers the risk of relapse when used as a maintenance therapy. The drug begins to show effects within the first two weeks of therapy, with continued improvement over subsequent weeks. Its efficacy is comparable to traditional SSRIs and SNRIs but with a significantly reduced incidence of sexual dysfunction, weight gain, and discontinuation symptoms, making it an attractive option for long-term treatment.
AGOBLISS 25 is well-tolerated by most patients, with liver function monitoring being the primary precaution due to the possibility of hepatotoxicity in susceptible individuals. Regular liver enzyme tests are recommended, particularly during the initial months of treatment. The tablet is taken once daily, preferably at bedtime, which aligns with its role in regulating circadian rhythms and minimizing potential side effects.
BluepillExpress manufactures AGOBLISS 25 TAB under internationally recognized quality standards including WHO-GMP and ISO certification. The manufacturing process utilizes high-purity raw materials and advanced formulation technology to ensure consistent drug delivery and bioavailability. Each batch is subjected to comprehensive quality control testing to verify potency, uniformity, and stability, ensuring the product meets strict pharmaceutical standards.
AGOBLISS 25 is presented in blister packs to preserve product integrity and ensure ease of distribution. The product is available for third-party and contract manufacturing under flexible terms and private labeling options. BluepillExpress offers comprehensive support, including product dossiers, regulatory assistance, and export documentation, to help partners expand into regulated and semi-regulated international markets. With the rising prevalence of depression and related mood disorders globally, there is a growing demand for well-tolerated and effective antidepressant therapies like Agomelatine.
The inclusion of Agomelatine on various international formularies reflects its clinical significance in modern psychiatric treatment. AGOBLISS 25 TAB is ideal for psychiatrists seeking to tailor treatment to patients with complex symptoms, particularly those who do not respond well to or tolerate other antidepressants. Its unique pharmacological profile also makes it suitable for patients with seasonal affective disorder, circadian rhythm sleep disorders, and depressive episodes with marked sleep disruption.
As a third-party manufacturer, BluepillExpress provides complete end-to-end solutions for clients looking to add AGOBLISS 25 TAB to their neuropsychiatric or mental wellness portfolio. From bulk supply to custom packaging and regulatory submission support, we ensure seamless product integration for healthcare providers, wholesalers, and pharmaceutical distributors. The combination of clinical efficacy, differentiated mechanism, and strong manufacturing support makes AGOBLISS 25 TAB a valuable asset in the treatment of depressive disorders and a competitive offering for global pharmaceutical markets.
In conclusion, AGOBLISS 25 TAB stands as a modern antidepressant therapy tailored to address both mood and circadian rhythm disturbances. Manufactured by BluepillExpress with a commitment to quality, safety, and therapeutic effectiveness, it represents a forward-thinking solution in mental health treatment. Its favorable tolerability, distinctive mode of action, and support for international distribution position it as a superior choice for both patients and pharmaceutical partners seeking excellence in depression care.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
